As Pfizer, Cipla negotiate terms, DCGI eases norms for clearing foreign-made COVID-19 vaccines
The Hindu
These exemptions have been made in light of the huge vaccination requirements in India
India’s apex drug regulator has waived the requirement of testing every batch of foreign-made vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such firms, a move that will bolster availability of vaccines. The decision by the Drugs Controller General of India (DCGI) comes in the backdrop of during negotiations to supply imported vaccines to India. These exemptions have been made in light of the huge vaccination requirements in India in the wake of the recent surge of COVID-19 cases and the need for increased availability of imported vaccines to meet national requirements, according to DCGI.More Related News